Business
AI becoming core infrastructure for pharmaceutical R&D, not just an experimental tool: Report
Artificial intelligence (AI) is rapidly becoming a core part of pharmaceutical research and development (R&D), moving beyond its role as an experimental technology to help companies accelerate drug discovery, improve research productivity…
More from Business
Piyush Goyal meets UAE, Indonesia trade ministers; discusses trade, investment ties on BRICS sidelines
Union Commerce and Industry Minister Piyush Goyal on Friday held separate meetings with his counterparts from the UAE and Indonesia on the…
“Someone writes, rumours are spread”: Hardeep Singh Puri dismisses cooking gas levy
Speaking at the 7th CII International Energy Conference, Puri challenged media reliance on unverified claims, stating, "Someone writes and rumours are spread…
AI Construction Platform Preckon Announces UAE Expansion Following Launch Event in Dubai
Dubai [UAE], August 7: In a significant milestone for international technology collaboration, Dr. E. Vishnu Vardhan Reddy, IFS, Consul General of India…
India’s Growing Interest in Financial Education Shows Why Classrooms Need to Evolve
New Delhi [India], August 7: When more than 300 students, young professionals and aspiring traders gathered at Vasant Kunj, New Delhi, for…
The Rise of E-commerce Reconciliation Software: How TheEcomWay Is Helping Marketplace Sellers Gain Greater Financial Visibility
New Delhi [India], August 7: India's e-commerce market has seen a significant rise over the last decade. With marketplaces like Amazon, Flipkart,…
Binance Research: Gen Z Investors are Starting Younger and Showing Greater Financial Discipline
Mumbai (Maharashtra) [India], August 7: Binance Research, the market research arm of the world's largest cryptocurrency exchange, Binance, has recently published a…